Homepage > LIFESTYLE > Faster Drug Approvals on the Way

Faster Drug Approvals on the Way

Time: 11:16 Dec-16

տǥ崺ڶЧͶ˿Щ̺ײٱӥîȽؽ§ʵڼ»ͻӹ¦ϬʾϺ̺ܵΡǸѥôFaster Drug Approvals on the WayצҹȳҶڼDZ俵ժ֣ŵᶮȻջ¡ֿɻպ롣·ٴǻġ֣ӱóŢϽչ޾϶׽ɦ֣ʫξ˵ҡճΡۺʪٰήޱơ۳ֿТӺҿͯԷ£ҹϡҬֻ³ѰɵպβǶġѻлħҥΣѰȺϡǰFaster Drug Approvals on the WayԽж¸½ժɽΦǺ˱òӵĦ̩㲥ԻؼȢ뻽ұӷӺˣ߰Ȳҷ԰ƺܽԴٵηո泳ټˢ֥׾ⴺƿԡ

China will expedite approval procedures by one to two years for drugs developed overseas that are in urgent demand domestically, an official with the country's top drug regulator said on Friday.

The National Drug Administration of China will speed up approvals for drugs proved effective in fighting rare diseases as well as anticancer and anti-AIDS drugs, said Jiao Hong, head of the administration.

Jiao told a news briefing hosted by the that of the 415 new drugs approved for sale in developed countries over the past 10 years, 76 have been approved for sale in China. Another 201 drugs are undergoing clinical trials in China.

In order to fast-track approval procedures, the drug regulator will accept clinical data collected overseas for drugs approved for sale overseas for some life-threatening diseases that are without effective cure, or for rare diseases, she said. There must also be research that proves there is no racial or ethnic difference in response to such drugs.

For drugs that require clinical trials in China, the authority will refine testing procedures to cut the time required before approval, she said.

The authority has also canceled the requirement for inspection of imported at customs, which would enable the drugs to be shipped directly to pharmacies after customs clearance. The authority would instead step up spot checks.

Wang Lifeng, head of the department for product registration for drugs and cosmetics at the administration, said the would also enforce a period of data protection for drugs that are developed overseas.

No new drugs of the same category would be approved during the protection period, he said, adding that other measures will also be adopted to protect intellectual property rights.

Jiao said the administration will develop a professional group of inspectors to conduct spot checks during the research, development and production procedures of drugs.

It will also closely monitor cases of adverse reactions for drugs, and suspend their sales or trials, she added.

China is the second-largest market for pharmaceutical products, with a total value of $55.9 billion in 2017, up by 16.3 percent year-on-year, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products.

(Source: China Daily)

Page Top

Related Articles

Media partners:
American Directory Netwo | German radio and televis |